Sun Pharmaceuticals Industries Ltd Nine Monthly Results

Gross Sales

39,225.67

35,945.12

32,553.3

29,040.34

24,769.34

Excise Duty

0

0

0

0

0

Net Sales

39,225.67

35,945.12

32,553.3

29,040.34

24,769.34

Other Operating Income

393.93

568.83

401.71

167.39

205.82

Other Income

1,352.17

748.25

261.24

807.92

1,012.8

Total Income

40,971.77

37,262.2

33,216.25

30,015.65

25,987.96

Total Expenditure

28,380.17

26,918.65

24,110.35

21,781.45

22,165.56

PBIDT

12,591.6

10,343.55

9,105.9

8,234.2

3,822.4

Interest

182.22

164.9

79.26

90.01

111.33

PBDT

12,409.38

10,178.65

9,026.64

8,144.19

3,711.07

Depreciation

1,911.6

1,906.28

1,857.9

1,587.27

1,526.46

Minority Interest Before NP

0

0

0

0

0

Tax

1,678.32

1,290.52

624.68

928.74

747.93

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

8,819.46

6,981.85

6,544.06

5,628.18

1,436.68

Minority Interest After NP

31.66

29.49

40.93

66.68

-579.73

Net Profit after Minority Interest

8,779.16

6,921.8

6,489.11

5,549.98

2,009.67

Extra-ordinary Items

-265.62

-331.42

0

-541.68

-1,912.03

Adjusted Profit After Extra-ordinary item

9,044.78

7,253.22

6,489.11

6,091.66

3,921.7

EPS (Unit Curr.)

36.6

28.8

27

23.1

8.38

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

1,050

850

750

700

550

Equity

239.93

239.93

239.93

239.93

239.93

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

32.1

28.77

27.97

28.35

15.43

PBDTM(%)

31.63

28.31

27.72

28.04

14.98

PATM(%)

22.48

19.42

20.1

19.38

5.8